In battle against the coronavirus
An almost irreplaceable organ
Living life to the fullest with dialysis
Growing up with parenteral nutrition
Paul, the four-legged therapist
The History of Dialysis
Serving patients in Swaziland
Using protons to take on cancer
On duty in disaster zones
Ready to help the littlest ones
"I want to help others, so they won’t give up"
From a local pharmacy to a global corporation
105,288,804 shares of total share capital are not listed.
Fresenius Group Overview
- The Health Care Group
-
Stories
-
![]()
In battle against the coronavirus
-
![]()
An almost irreplaceable organ
-
![]()
Living life to the fullest with dialysis
-
![]()
Growing up with parenteral nutrition
-
![]()
Paul, the four-legged therapist
-
![]()
The History of Dialysis
-
![]()
Serving patients in Swaziland
-
![]()
Using protons to take on cancer
-
![]()
On duty in disaster zones
-
![]()
Ready to help the littlest ones
-
![]()
"I want to help others, so they won’t give up"
-
![]()
From a local pharmacy to a global corporation
-
-
Investors
-
New Developments
- Capital Markets Day
- Share
- Investor News
- Strategy & Outlook
- Events & Presentations
- Financial Reports
- Results Center
- Ad-hoc News
- Group Figures
- Annual General Meeting
- Credit Relations
- FAQ
- Contacts
![]()
Contact
Fresenius SE & Co. KGaA
Investor Relations & Sustainability
+49 (0) 6172 608-2485
ir-fre@fresenius.com -
New Developments
-
Media
![]()
Contact
Matthias Link
Senior Vice President Corporate Communications
T: +49 (0) 6172 608-2872
matthias.link@fresenius.com - Careers
Capitalization
-
Share Price
Data is delayed by 15 minutes.
Share Price Information -
Related Links
-
Library
-
Event
May 06, 2020 | Bad Homburg, Germany
Conference Call Q1 2020, Fresenius
-
FAQ
Fresenius SE & Co. KGaA's subscribed capital amounts to €557,409,904 and consists of 557,409,904 ordinary shares (as of 31.03.2020). The shares are notional no-par-value shares. Each share represents €1.00 of the capital stock.
Capitalization 2020
|
Date |
Capital-related measures |
Subscribed Capital / Total number of ordinary Shares |
| 31.01.2020 | Issuance of new shares from stock option plan | €557,381,104 / 557,381,104 |
| 29.02.2020 | Issuance of new shares from stock option plan | €557,399,854 / 557,399,854 |
| 31.03.2020 | Issuance of new shares from stock option plan | €557,409,904 / 557,409,904 |
-
Development of capital stock since it went public in 1986
Date
Capital-related measures
Subscribed Capital
Nominal Value
Total number of
preference sharesTotal number of ordinary shares
2019 Issuance of new shares from stock option plan
€ 557,379,979 557,379,979 2018 Issuance of new shares from stock option plan
€ 556,225,154 556,225,154 2017 Issuance of new shares from stock option plan
€ 554,710,473 554,710,473 31.01.2017 Capital increase from approved capital
€ 553,316,547 553,316,547 2016 Issuance of new shares from stock option plan
€ 547,208,371 547,208,3712015 Issuance of new shares from stock option plan
€ 545,727,950
545,727,950 2014 Issuance of new shares from stock option plan
€ 541,532,600 541,532,600 01.08.2014 Stock split with Capital increase from company funds
€ 540,511,632 540,511,632 31.07.2014 Issuance of new shares from stock option plan
€ 180,170,544 180,170,544 2013 Issuance of new shares from stock option plan
€ 179,694,829 179,694,829 2012 Issuance of new shares from stock option plan
€ 178,188,260 178,188,260 15.05.2012 Capital increase from approved capital
€ 177,166,002 177,166,002 30.04.2012 Issuance of new shares from stock option plan
€ 163,366,002 163,366,002 2011 Issuance of new shares from stock option plan
€ 163,237,336 163,237,336 28.01.2011 Unification of share classes
€ 162,450,090 162,450,090 2010 Issuance of new shares from stock option plan (P&O)
€ 162,450,090 81,225,045 81,225,045 2009 Issuance of new shares from stock option plan (P&O)
€ 161,315,376 80,657,688 80,657,688 2008 Issuance of new shares from stock option plan (P&O)
€ 161,143,734 80,571,867 80,571,867 Capital increase from approved capital
€ 160,863,550 80,426,775 80,426,775 Issuance of new shares from stock option plan (P&O)
€ 155,357,436 77,678,718 77,678,718 2007 Issuance of new shares from stock option plan (P&O)
€ 155,164,770 77,582,385 77,582,385 Share split with capital increase from the Company's funds4
€ 154,353,876 77,176,938 77,176,938 2006 Issuance of new shares from stock option plan (P&O)
€ 131,715,308 25,725,646 25,725,646 17.11.2006 Capital increase through contribution in kind (P&O)
€ 131.524.890 176,540 176,540 2005 Capital increase from approved capital 9:2 (P&O)
€ 129,849,037 25,361,140 25,361,140 2005 Issuance of new shares from stock option plan (P&O)
€ 105,785,037 20,661,140 20,661,140 2004 Issuance of new shares from stock option plan (P&O)
€ 104,885,857 20,485,519 20,485,519 2002 Issuance of new shares from stock option plan (P&O)
€ 104,882,391 20,484,842 20,484,842 2001 Issuance of new shares from stock option plan (P&O)
€ 104,882,043 20,484,774 20,484,774 Capital increase through contribution in kind (P&O)
€ 104,800,266 20,468,802 20,468,802 Capital increase from corporate funds by new share issue in the ratio 1:1 (P&O)
€ 102,477,865 20,015,208 20,015,208 Issuance of new shares from stock option plan (P&O)
€ 51,238,932 10,007,604 10,007,604 2000 Issuance of new shares from stock option plan (P&O)
€ 51,238,523 10,007,524 10,007,524 1999 Conversion of subscribed capital into € and introduction of non-par shares3
€ 51,200,000 10,000,000 10,000,000 1997 Capital increase (P)
DM 100,000,000 DM 5 10,000,000 10,000,000 1995 Change of nominal value from DM 50 to DM 5
DM 90,000,000 DM 5 8,000,000 10,000,000 1994 Capital increase (P)
DM 90,000,000 DM 50 800,000 1,000,000 1992 Capital increase / listing (O)2
DM 80,000,000 DM 50 600,000 1,000,000 1989 Capital increase (P)
DM 60,000,000 DM 50 600,000 600,000 1986 Listing at Frankfurt Stock Exchange (P)1
DM 45,000,000 DM 50 300,000 600,000 - 1 (P) = Preference Shares
- 2 (O) = Ordinary Shares
- 3 Par value per share € 2.56
- 4 Par value per share € 1.00
Contact us
Fresenius SE & Co. KGaA
Else-Kröner-Str. 1
61352 Bad Homburg v.d.H.
Germany
T +49 (0) 6172 608-0
pr-fre@fresenius.com
Contacts
